Molecular Pathology: is an emerging discipline within pathology that is focused on the study and diagnosis of disease through the examination of molecules within organs, tissues or bodily fluids. Molecular pathology shares some aspects of practice with both anatomic pathology and clinical pathology, molecular biology, biochemistry, proteomics and genetics, and is sometimes considered a "crossover" discipline. It is multi-disciplinary in nature and focuses mainly on the sub-microscopic aspects of disease.
-
Interpreting genomic test results for cancer care remains a significant challenge, with variability in turnaround times, reporting standards, and clinical utility impacting patient outcomes....
This webinar explores cutting-edge advancements in ultra-deep circulating tumor DNA (ctDNA) sequencing, integrating artificial intelligence (AI) and precision oncology to address critical ch...
MAR 26, 2024 | 7:00 PM
C.E. CREDITS
The implementation of a preemptive pharmacogenomics (PGx) program in a hospital setting requires a multidisciplinary approach to ensure seamless integration of each stage of the process for...
Ever wonder what you’re missing in your data? The sheer complexity of today’s flow and mass cytometry datasets demands automated solutions. Machine learning plugins only provide...
MAR 26, 2024 | 8:00 AM
C.E. CREDITS
The implementation of a preemptive pharmacogenomics (PGx) program in a hospital setting requires a multidisciplinary approach to ensure seamless integration of each stage of the process for...
MAR 14, 2024 | 3:00 PM
C.E. CREDITS
The practice of diagnostic pathology has gone through a disruptive transformation in which multiple tools such as digital imaging, advanced artificial intelligence algorithms, and computer-a...
In this webinar, we will briefly introduce Vizgen’s Vizgen® MERSCOPE® Platform for spatial transcriptomics. Following this introduction, we will showcase the capabilities of ME...
Dr. Christopher E. Mason Professor of Genomics, Physiology, and Biophysics at Weill Cornell Medicine and the Director of the WorldQuant Initiative for Quantitative Prediction Digital PCR for...
FEB 27, 2024 10:00am CET, 9:00am GMT
10:00am PT, 12:00pm CT, 1:00pm ET: Welcome 10:15am PT, 12:15pm CT, 1:15pm ET: Digital PCR for minimal residual disease research and cancer research Dr. Christopher E. Mason Professor of Geno...
FEB 27, 2024 9:30am IST, 12:00pm CST/SGT
10:00am PT, 12:00pm CT, 1:00pm ET: Welcome 10:15am PT, 12:15pm CT, 1:15pm ET: Digital PCR for minimal residual disease research and cancer research Dr. Christopher E. Mason Professor of Geno...
In 2020, American Cancer Society released an updated cervical cancer screening guideline calling for primary human papillomavirus (HPV) screening as the preferred strategy. Utility of HPV pr...
Over the course of the COVID-19 pandemic, there has been a dramatic increase in the number and type of diagnostic tests for respiratory viruses. These include targeted molecular assays, smal...
According to the most recent data from UNAIDS, in 2022, there were around 39 million people living with HIV worldwide. Of these, 5.5 million people were unaware of their diagnosis in 2021. M...
Pathology Perspective: Discover the critical need for genomic testing in cancer and explore the differences between traditional tissue biopsies and liquid genomic profiling. We'll dive i...